Subscribe To
Gm and ge agree to develop supply chains to support ev production, renewable energy growth
General Motors Co. GM, +0.67% and General Electric Co. GE, said Wednesday that they signed a memorandum of understanding (MOU) to improve supplies of ...
October 6, 2021, 7:54 am
Gm and ge agree to develop supply chains to support ev production, renewable energy growth
General Motors Co. GM, +0.67% and General Electric Co. GE, said Wednesday that they signed a memorandum of understanding (MOU) to improve supplies of ...
October 6, 2021, 7:54 am
Gm and ge agree to develop supply chains to support ev production, renewable energy growth
General Motors Co. GM, +0.67% and General Electric Co. GE, said Wednesday that they signed a memorandum of understanding (MOU) to improve supplies of ...
October 6, 2021, 7:54 am
Exxonmobil increases participation in scotland carbon capture and storage project
IRVING, Texas--(BUSINESS WIRE)--ExxonMobil has increased its participation in the proposed Acorn carbon capture project in Scotland by signing an Expr...
October 6, 2021, 3:00 am
Exxonmobil increases participation in scotland carbon capture and storage project
IRVING, Texas--(BUSINESS WIRE)--ExxonMobil has increased its participation in the proposed Acorn carbon capture project in Scotland by signing an Expr...
October 6, 2021, 3:00 am
Exxonmobil increases participation in scotland carbon capture and storage project
IRVING, Texas--(BUSINESS WIRE)--ExxonMobil has increased its participation in the proposed Acorn carbon capture project in Scotland by signing an Expr...
October 6, 2021, 3:00 am
Mindmed teams up with sphere health to identify biomarkers associated with anxiety & depression
Psychedelic–focused biotech company Mind Medicine Inc. (NASDAQ: MNMD) (NEO: MMED) (DE: MMQ) disclosed on Tuesday that it has agreed to partner with...
October 5, 2021, 1:15 pm
Mindmed teams up with sphere health to identify biomarkers associated with anxiety & depression
Psychedelic–focused biotech company Mind Medicine Inc. (NASDAQ: MNMD) (NEO: MMED) (DE: MMQ) disclosed on Tuesday that it has agreed to partner with...
October 5, 2021, 1:15 pm
Mindmed teams up with sphere health to identify biomarkers associated with anxiety & depression
Psychedelic–focused biotech company Mind Medicine Inc. (NASDAQ: MNMD) (NEO: MMED) (DE: MMQ) disclosed on Tuesday that it has agreed to partner with...
October 5, 2021, 1:15 pm
Mindmed teams up with sphere health to identify biomarkers associated with anxiety & depression
Psychedelic–focused biotech company Mind Medicine Inc. (NASDAQ: MNMD) (NEO: MMED) (DE: MMQ) disclosed on Tuesday that it has agreed to partner with...
October 5, 2021, 1:15 pm
Mindmed teams up with sphere health to identify biomarkers associated with anxiety & depression
Psychedelic–focused biotech company Mind Medicine Inc. (NASDAQ: MNMD) (NEO: MMED) (DE: MMQ) disclosed on Tuesday that it has agreed to partner with...
October 5, 2021, 1:15 pm
Mindmed teams up with sphere health to identify biomarkers associated with anxiety & depression
Psychedelic–focused biotech company Mind Medicine Inc. (NASDAQ: MNMD) (NEO: MMED) (DE: MMQ) disclosed on Tuesday that it has agreed to partner with...
October 5, 2021, 1:15 pm
Mindmed teams up with sphere health to identify biomarkers associated with anxiety & depression
Psychedelic–focused biotech company Mind Medicine Inc. (NASDAQ: MNMD) (NEO: MMED) (DE: MMQ) disclosed on Tuesday that it has agreed to partner with...
October 5, 2021, 1:15 pm
Roche to present new data on ocrevus in multiple sclerosis and enspryng in neuromyelitis optica spectrum disorder at ectrims 2021
Basel, 5 October 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that new OCREVUS® (ocrelizumab) and ENSPRYNG® (satralizumab) data will be...
October 5, 2021, 1:00 am
Roche to present new data on ocrevus in multiple sclerosis and enspryng in neuromyelitis optica spectrum disorder at ectrims 2021
Basel, 5 October 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that new OCREVUS® (ocrelizumab) and ENSPRYNG® (satralizumab) data will be...
October 5, 2021, 1:00 am
Roche to present new data on ocrevus in multiple sclerosis and enspryng in neuromyelitis optica spectrum disorder at ectrims 2021
Basel, 5 October 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that new OCREVUS® (ocrelizumab) and ENSPRYNG® (satralizumab) data will be...
October 5, 2021, 1:00 am
Roche to present new data on ocrevus in multiple sclerosis and enspryng in neuromyelitis optica spectrum disorder at ectrims 2021
Basel, 5 October 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that new OCREVUS® (ocrelizumab) and ENSPRYNG® (satralizumab) data will be...
October 5, 2021, 1:00 am
Roche to present new data on ocrevus in multiple sclerosis and enspryng in neuromyelitis optica spectrum disorder at ectrims 2021
Basel, 5 October 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that new OCREVUS® (ocrelizumab) and ENSPRYNG® (satralizumab) data will be...
October 5, 2021, 1:00 am
Roche to present new data on ocrevus in multiple sclerosis and enspryng in neuromyelitis optica spectrum disorder at ectrims 2021
Basel, 5 October 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that new OCREVUS® (ocrelizumab) and ENSPRYNG® (satralizumab) data will be...
October 5, 2021, 1:00 am
Roche to present new data on ocrevus in multiple sclerosis and enspryng in neuromyelitis optica spectrum disorder at ectrims 2021
Basel, 5 October 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that new OCREVUS® (ocrelizumab) and ENSPRYNG® (satralizumab) data will be...
October 5, 2021, 1:00 am